Cargando…

Mitochondrial replacement techniques : ethical, social, and policy considerations /

Mitochondrial replacement techniques (MRTs) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child. While MRTs, if effective, could satisfy a desire of women seeking to have a genetically related child without the risk of passing on mtDNA disease, the tec...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Claiborne, Anne B. (Editor ), English, Rebecca A. (Editor ), Kahn, Jeffrey P. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, [2016]
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn945556529
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 160503s2016 dcua obt 000 0 eng
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d MMU  |d N$T  |d YDXCP  |d OCLCO  |d EBLCP  |d IDB  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d BUF  |d SNK  |d DKU  |d AUW  |d MHW  |d IGB  |d D6H  |d OCLCF  |d VTS  |d EZ9  |d AGLDB  |d OCLCQ  |d G3B  |d S8J  |d S9I  |d VT2  |d STF  |d OCLCQ  |d NLM  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d SFB  |d LVT  |d OCLCO  |d K6U  |d OCLCO  |d DST  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 101683293  |2 DNLM 
019 |a 1021261991  |a 1144239970  |a 1162003355  |a 1229416640  |a 1261771637  |a 1262690407  |a 1290042108  |a 1300619220 
020 |a 9780309388702 
020 |a 0309388708 
020 |a 9780309388719 
020 |a 0309388716 
020 |a 0309388732 
020 |a 9780309388733 
029 0 |a NLM  |b 101683293 
029 1 |a AU@  |b 000066655589 
029 1 |a DEBBG  |b BV043893234 
029 1 |a NZ1  |b 16338280 
029 1 |a AU@  |b 000057278163 
035 |a (OCoLC)945556529  |z (OCoLC)1021261991  |z (OCoLC)1144239970  |z (OCoLC)1162003355  |z (OCoLC)1229416640  |z (OCoLC)1261771637  |z (OCoLC)1262690407  |z (OCoLC)1290042108  |z (OCoLC)1300619220 
042 |a pcc 
043 |a n-us--- 
050 4 |a RG133.5 
060 0 0 |a 2016 E-349 
060 1 0 |a WQ 208 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.6/92  |2 23 
049 |a UAMI 
245 0 0 |a Mitochondrial replacement techniques :  |b ethical, social, and policy considerations /  |c Anne Claiborne, Rebecca English, Jeffrey Kahn, editors ; Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Board on Health Sciences Policy, Institute of Medicine, National Academies of Sciences, Engineering, and Medicine. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2016] 
300 |a 1 online resource (1 PDF file (xvi, 184 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a Mitochondrial replacement techniques (MRTs) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child. While MRTs, if effective, could satisfy a desire of women seeking to have a genetically related child without the risk of passing on mtDNA disease, the technique raises significant ethical and social issues. It would create offspring who have genetic material from two women, something never sanctioned in humans, and would create mitochondrial changes that could be heritable (in female offspring), and therefore passed on in perpetuity. The manipulation would be performed on eggs or embryos, would affect every cell of the resulting individual, and once carried out this genetic manipulation is not reversible. Mitochondrial Replacement Techniques considers the implications of manipulating mitochondrial content both in children born to women as a result of participating in these studies and in descendants of any female offspring. This study examines the ethical and social issues related to MRTs, outlines principles that would provide a framework and foundation for oversight of MRTs, and develops recommendations to inform the Food and Drug Administration's consideration of investigational new drug applications. 
536 |a This activity was supported by Contract No. HHSP233201400020B/HHSP2337010 between the National Academy of Sciences and the U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed May 27, 2016). 
505 0 |a Introduction -- Science and policy context -- Do ethical, social, and policy considerations preclude MRT? -- Regulation and oversight of MRT in humans. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Reproductive technology  |x Moral and ethical aspects  |z United States. 
650 0 |a Reproductive technology  |x Government policy  |z United States. 
650 0 |a Mitochondrial DNA  |x Abnormalities  |z United States. 
650 0 |a Mitochondrial pathology  |z United States. 
650 0 |a Medical ethics  |z United States. 
650 0 |a Mitochondrial DNA. 
650 1 2 |a Mitochondrial Replacement Therapy  |x ethics 
650 2 2 |a Mitochondrial Diseases  |x prevention & control 
650 2 2 |a DNA, Mitochondrial 
650 6 |a Reproduction  |x Innovations  |x Aspect moral  |z États-Unis. 
650 6 |a Reproduction  |x Innovations  |x Politique gouvernementale  |z États-Unis. 
650 6 |a Maladies mitochondriales  |z États-Unis. 
650 6 |a Éthique médicale  |z États-Unis. 
650 6 |a ADN mitochondrial. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Mitochondrial DNA  |2 fast 
650 7 |a Medical ethics  |2 fast 
650 7 |a Mitochondrial DNA  |x Abnormalities  |2 fast 
650 7 |a Mitochondrial pathology  |2 fast 
650 7 |a Reproductive technology  |x Moral and ethical aspects  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
700 1 |a Claiborne, Anne B.,  |e editor. 
700 1 |a English, Rebecca A.,  |e editor. 
700 1 |a Kahn, Jeffrey P.,  |e editor. 
710 2 |a Institute of Medicine (U.S.).  |b Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases,  |e issuing body. 
776 0 8 |i Print version:  |t Mitochondrial replacement techniques.  |d Washington, D.C. : National Academies Press, 2016  |z 9780309388702  |w (OCoLC)933521007 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4455148  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36564604 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36618204 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4455148 
938 |a EBSCOhost  |b EBSC  |n 1179498 
938 |a YBP Library Services  |b YANK  |n 12902979 
994 |a 92  |b IZTAP